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Abstract:  
Robots that reside inside the body to restore or enhance biological function have long been a staple 
of science fiction. Creating such robotic implants poses challenges both in signaling between the 
implant and the biological host as well as in implant design. To investigate these challenges, we 
created a robotic implant to perform in vivo tissue regeneration via mechano-stimulation. The 
robot is designed to induce lengthening of tubular organs, such as the esophagus and intestines, by 
computer-controlled application of traction forces. Esophageal testing in swine demonstrates that 
the applied forces can induce cell proliferation and lengthening of the organ without a reduction 
in diameter, while the animal is awake, mobile and able to eat normally. Such robots can serve as 
research tools for studying mechanotransduction-based signaling and can also be employed 
clinically for conditions such as long-gap esophageal atresia and short bowel syndrome.   
One Sentence Summary:  
We have created a robotic implant for inducing tissue growth in tubular organs and demonstrated 
its potential through esophageal lengthening in swine. 
 
Introduction  
Robotics has been successfully applied to the restoration of human health as well as to the 
augmentation of human capabilities. Clinically-approved robots are available for performing 
minimally invasive surgical procedures (1, 2) and for assisting stroke victims in relearning motor 
control tasks (3, 4). Robotic prostheses have been designed to replace human limbs (5, 6) while 
soft and hard exoskeletons are being developed to enhance human strength and endurance (7, 8). 
These types of robots, however, respond only to conscious motion commands. Also, these robots 
2 
 
either remain outside the human body or enter the body for a short period of time, typically the 
duration of a medical procedure. In contrast, robotic implants represent an unexplored frontier. 
Such devices can be implanted in the body for an extended period of time and interact mechanically 
with tissues to regulate tissue forces or fluid flow rates (9) in response to sensed physiological 
signals as well as external commands. 
One intriguing application for robotic implants is mechano-stimulation-modulated tissue 
regeneration. While in vivo tissue engineering is based on the implantation of a cell-seeded 
scaffold, an alternate approach is to employ mechanical stimulation of existing tissues to induce 
their growth. Mechanotransduction or cell signaling using mechanical forces is well known to be 
related to cell proliferation and growth (10±14), and is clinically applied in distraction osteogenesis 
for inducing bone growth (15), tissue expanders for producing skin grafts (16) and in wound 
healing (17). When healthy tissue of the desired type is present in the body, mechanically-induced 
growth can avoid many of the challenges of traditional tissue engineering, e.g., cell death prior to 
vascularization of the scaffold, immunogenic response to synthetic scaffolds, and mismatch 
between desired and actual tissue properties (18±20).  
The lengthening of tubular organs, such as the esophagus, intestines and vasculature, is well suited 
to mechanically stimulated growth (21±23); though, the multifunctional nature of these organs, 
e.g., providing peristalsis and nutrient absorption, complicates the process in comparison to bone 
or skin. In addition, the approach in which growth-inducing forces are applied should not 
compromise current organ functionality by occluding flow (22) and, furthermore, should be 
minimally disabling to the patient, e.g., not require medically-induced sedation and paralysis as 
employed during treatments of esophageal atresia (21).  
We report a robotic implant for tubular organ lengthening that addresses these challenges. It 
enables both automatic and operator-controlled mechanical force modulation based on sensor 
measurements of tissue displacement and force. The system serves as both a research tool for 
studying tissue-scale mechano-stimulation and as a precursor to a clinical device. We demonstrate 
the potential of robotically-induced tissue growth through in vivo porcine esophageal lengthening 
experiments during which the animals were awake, able to eat and move normally. 
Results 
We designed the robotic implant, first conceptualized in (24), to attach to the exterior of either 
disconnected or connected tubular organ segments (Fig. 1A,B) by two attachment rings. The 
implant body is positioned adjacent to the organ and is sized to avoid damage to surrounding tissue. 
It is covered in a smooth biocompatible waterproof skin that completely seals the interior motor, 
sensors and electronics from bodily fluids and enables gas sterilization (Fig. 1C,D). Traction is 
generated by translation of the lower attachment ring, which can move freely along the implant 
body due to the folds in the skin.  
The open-ring geometry of the attachment rings (Fig. 1E) maintains the diameter of the lengthened 
organ while enabling attachment to both disconnected (Fig. 1A, esophageal atresia) and connected 
(Fig. 1B, bowel and vasculature) organ segments. Since the rings and implant are exterior to the 
organ, they do not occlude internal flow. The rings attach to the implant by sliding connectors 
allowing them to be first sutured to the organ without the implant obstructing the surgical field 
(Fig. 1F). To avoid the potential of creating a leak if a suture was to tear out of the tissue, the 
sutures are placed so that they do not penetrate the organ lumen.  
The implant was designed such that the only forces it generates are equal, opposite and collinear 
forces applied to the tubular organ (Fig. 1A,B). This strategy decouples traction forces from the 
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SDWLHQW¶Vphysiological movement to avoid the risks and lifestyle impairment associated with some 
current techniques. For example, in the clinical treatment of long-gap esophageal atresia, forces 
applied to the esophageal segments are generated via passive UHDFWLRQIRUFHVRQWKHSDWLHQW¶VEDFN
(Fig. 1G) (21). Patients are maintained in a state of sedation and paralysis in the ICU for the 
duration of traction (1-4 weeks) so that the sutures do not tear out of the esophagus due to 
musculoskeletal motion.  
The implant body contains a motor that controls the position of the lower ring, as well as sensors 
that measure the distance between the rings and the force on the lower ring (Fig. 1D). The implant¶V
microcontroller, communication chip, and battery power supply are located in a wearable control 
unit outside the host, which is connected by cable to the implant body (Figs. 2A,4D). The 
microcontroller was programmed to provide a variety of functionality. For the studies reported 
here, a basic control mode was used in which the force applied by the rings or the distance between 
them could be commanded wirelessly from a laptop computer that is also used for data logging 
and visualization (Fig.  2A). This mode was used for two reasons. First, we wanted to mimic the 
daily fixed displacements of clinical practice. Second, for reasons of animal safety in testing a new 
device, we wanted to be present to ensure the animal was not undergoing distress when traction 
was adjusted. More complex robotic control is also possible, such as removing the applied force 
when the implant detects that the animal is feeding.   
We experimentally verified the capability of the robotic implant to induce tubular tissue growth 
on healthy connected esophagus in swine. This approach combines the more stringent implant size 
requirement of esophageal lengthening )LJ$ZLWKHYDOXDWLRQRIWKHRUJDQ¶VWUDQVSRUWDELOLW\
during traction as is necessary during bowel lengthening (Fig. 1B). Two groups of animals were 
used: a surgical group (n=5) that received the implant, and a naïve group (n=3) that did not. In the 
surgical group, the rings were sutured to the esophagus at an initial separation distance of 20.2 +/- 
0.8mm. To track esophageal lengthening outside the traction zone, e.g., due to animal growth, 
control segments were marked 20mm proximal and 20mm distal to the attachment rings using 
pairs of X-ray-visible surgical clips. Each pair of clips marked a ~20mm segment. In this way, 
each animal acted as its own control so that tissue changes due to the presence of the implant could 
be distinguished from changes due to applied force.  
Traction was started two days after implantation (Day 2) and ring separation distance was 
increased by an average of 2.5mm each day (Fig. 2B) through Day 9 (n=2) or Day 10 (n=3). 
Following a rapid increase in ring separation distance, the measured force was observed to increase 
equally rapidly and then decrease following an approximately exponential decay over the 
subsequent 24-hour period (Fig. 2B). The daily ring displacement, however, ensured that the force 
and strain on the loaded segment did not reach zero owing to the lengthening that occurs over the 
subsequent 24-hour period. Note that the force spikes in Fig. 2B occurring at 7:30AM and 4PM 
correspond to meal times when the pig was eating. 
The animals did not display any signs of discomfort due to adjustment and fluoroscopic 
examination indicated normal flow through the stretched region (Fig. 2C, Movie S1). Furthermore, 
all animals expressed normal appetite, consumed the provided amount of food (based on animal 
weight and age) and passed stool. Despite having undergone a major surgery, all animals gained 
weight (weight gain of 2.2 +/- 1.3 kg). 
The implant-reported distance between the rings was in agreement with the distance as derived 
from X-ray and fluoroscopic images taken to assess the adjustments on Days 0 and 4, and on the 
final day (Day 10 or 11) (Fig. 2D).  
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On the final day, to measure total elongation in vivo, we iteratively adjusted the ring separation 
distance to remove the residual force and strain and then recorded the corresponding ring distance. 
The distances before and after removal of residual strain are shown in Fig. 2D. The zero-strain 
length increased by 77 +/- 13% (mean ± standard deviation), over the 8-9 days of force application. 
These measurements, which were in agreement with physical measurements taken at necropsy 
(Fig. 2E), demonstrated a statistically significant increase with respect to the clip-marked 
esophageal sections above and below the implant, which increased in length by 10 +/- 12%.  
In congruity with clinical practice, a fibrous capsule (Fig. 4E) formed around the silastic sheet 
(Fig. 4C) enveloping the implant and esophagus. The capsule was found to be easily removable 
from both the implant and the esophagus.  
 While esophageal lengthening is performed clinically, there is controversy as to whether the 
esophageal segments are growing or simply stretching (25). To investigate this, we first studied 
the geometry of the lengthened samples. The excised esophagi were cut longitudinally and 
unrolled showing a healthy appearance of the mucosa (Fig. 2E). The tissue width (esophagus 
circumference) measured 8.2 +/- 1.4mm between the rings and 8.9 ± 1.5mm and 8.7 ± 2.1mm in 
the proximal and distal control segments, respectively, indicating that the tissue is uniform along 
the entire length and elongation has preserved lumen diameter within a fraction of a millimeter. 
The cross section of the esophagus is comprised of five tissue layers (Fig. 3A): the muscularis 
externa, submucosa, muscularis mucosa, lamina propria and epithelium (26). The muscularis 
externa is the thickest layer and is comprised of a mixture of skeletal and smooth muscle cells 
arranged in longitudinal and circular sublayers. The structure of this layer facilitates investigation 
into whether lengthening is due to growing or stretching, as described below.  
To measure how the thickness of this layer may have changed, we studied tissue samples stained 
ZLWK0DVVRQ¶Vtrichrome. Statistical analysis shows that the thickness of the lengthened muscular 
layer was preserved with respect to the adjacent control segments and also with respect to tissue 
taken from the naïve group (Figure 5A).  
Since both the circumference and thickness of the muscularis externa are maintained during 
lengthening, its volume has increased. Further testing was performed to understand if this volume 
increase was due to cellular hypertrophy, proliferation, the generation of fibrosis or a combination 
of these effects.  
To explore if lengthening could be attributed to muscle cell hypertrophy, we compared skeletal 
muscle fiber cross section in both circular and longitudinal muscle layers of the muscularis externa 
(Fig. 3B). We found no statistically significant difference in fiber cross section between the 
lengthened tissue and tissue collected from the set of naïve swine indicating that lengthening is not 
due to muscle hypertrophy (Fig 5B).  
We also used DAPI immunofluorescent staining to compare the nuclear density of the muscularis 
externa in the surgical group with naïve swine tissue (Fig. 3C) and found no statistically significant 
difference (Fig. 5C). The observed trend of increasing nuclear density from proximal to distal 
segments can be explained as follows. The muscular layers in the esophagus are a mixture of 
skeletal and smooth muscle cells. The ratio of skeletal to smooth cells varies along its length with 
a larger proportion of skeletal muscle cells in the proximal region and a smaller proportion in the 
distal region. Smooth muscle has a larger number of nuclei than skeletal muscle and so the 
observed variation in nuclear density is to be expected.  
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We also quantified the nuclear density of the inner epithelial layer, which does not vary in 
composition along the esophageal length. No statistical difference in nuclear density was found 
between the three regions of the surgical and naïve groups (Fig. 5D).   
As a definitive demonstration of cellular proliferation, we compared nuclear proliferation in the 
muscle cells of the muscularis externa using a Ki67 and Desmin staining protocol. We observed a 
statistically significant increase in proliferation of muscle cells in the lengthened tissue compared 
to tissue from the naïve group (Fig. 5E).  
All of these results indicate that tissue growth has occurred. To quantify in the muscle layers what 
fraction of lengthening is due to muscle cell proliferation and what fraction is due to fibrosis, 
0DVVRQ¶V trichrome staining was used to quantify the relative fraction of muscle and collagen 
measured by area (Fig. 3D). In the naïve animal tissue, the muscle / collagen ratio was 93% / 7%. 
In the lengthened segments, the muscle / collagen ratio was 80% / 20% (Fig. 5F). As detailed in 
Materials and Methods, since the collagen is interspersed between groups of muscle cells, these 
ratios can be used to divide the average lengthening of 77% into components due to muscle cell 
proliferation (49%) and collagen proliferation (28%). Put another way, 63% of lengthening is due 
to muscle cell proliferation and 37% is due to collagen formation (compared to 93% / 7% if the 
original ratio of muscle / collagen had been maintained).  
Discussion 
These are the first results to demonstrate in a large animal model that esophageal traction-induced 
lengthening is not due to stretching (change in cross section dimensions or cellular hypertrophy), 
but rather a combination of cellular proliferation and fibrosis.  
Our robotic implant establishes that lengthening of tubular organs can be achieved in a precisely 
controlled manner that maintains organ geometry, preserves organ functionality, and eliminates 
the need for patient immobilization during growth. Furthermore, by exploiting tissue-level 
mechano-stimulation, the standard challenges of tissue engineering are avoided.  
Robotic implants offer substantial benefits compared to the static approaches currently applied to 
esophageal, bone and skin growth. This includes the capability to apply dynamic time-varying 
strains based on the physiological processes of the tissue. In clinical practice, strain adjustments 
for esophageal, bone and tissue expansion are performed in discrete steps on a daily or weekly 
basis. Such clinical regimens, as reproduced in the experiments reported here, do induce organ 
growth, but can also alter tissue properties, e.g., produce fibrosis. It is well known, however, that 
tissue responds not only to static strains, but also to dynamic loading. Examples from tissue 
engineering include skeletal muscle (27), smooth muscle (28), cartilage (29) and arteries (30). 
Furthermore, periodic relaxation of traction may enhance tissue perfusion. And while 
mechanotransduction has been studied on the cellular level (10,11), little is known at the organ 
level about the mechanisms governing mechano-stimulated organ growth. Robotics provides the 
capability to study these mechanisms and to apply what is learned clinically in order to optimize 
organ morphology, function and growth rate.  
Robotics also provides the ability to respond autonomously to changes in the biological system. A 
simple example is adapting the adjustment of strain to accommodate actual growth during the 
lengthening process. Some existing methods adjust tissue loading by the same amount every day 
± resulting in a daily decrease in applied strain as the tissue lengthens. In other cases, e.g., skin 
expansion, the amount of adjustment is based on palpation to assess tissue tightness and perfusion. 
A force- or pressure-sensing robotic device can be programmed to consistently provide the desired 
level of strain by regularly recalibrating itself to account for actual growth.  
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More complex interaction with the biological host is also possible, such as removing the applied 
strain when the implant senses specific physiological activity. For example, in our porcine 
experiments, it was possible to detect when the animal was eating based on force spikes (Fig. 2B). 
While our monitoring of the animals indicated that the applied strain did not cause them discomfort 
while swallowing, the robotic implant could have removed the applied force until it sensed that 
the animal had finished eating. Similarly, in bowel lengthening, a robotic implant could be 
programmed to detect peristalsis and relax for a period of time to facilitate passage of food.  
While robotics can significantly enhance mechano-stimulated organ growth, there are potential 
limitations to what it can achieve. For example, long-gap esophageal atresia, as a congenital 
condition, is treated when patients are children and growing. While bone lengthening and skin 
expansion are performed successfully in adults, it is unknown whether the mechanisms that induce 
lengthening in the pediatric esophagus are still active in adults. Furthermore, the nerves controlling 
esophageal contraction run along its length. In cases of esophageal atresia, the nerves are 
interrupted and do not fully regenerate after anastomosis. Despite impaired peristalsis, however, 
the repaired esophagus, aided by gravity in humans, successfully performs its main function as a 
conduit to the stomach. In our swine studies, the continued effectiveness of the esophagus was 
demonstrated by normal function of the alimentary canal and by animal weight gain. Even if 
esophageal motility were to have some impairment from growth induction, the ability to achieve 
an intact esophageal conduit would remain preferable to surgical alternatives such as esophageal 
replacement where normal esophageal motility would clearly not be expected. 
Beyond their use for organ growth, robotic implants represent a new direction in medical robotics. 
These bionic systems can assist in performing normal body functions either temporarily, until the 
body repairs itself, or permanently. The ongoing miniaturization of sensors (31) and actuators (32) 
together with the continuing development of techniques for wireless communication, power 
transfer (33, 34) and energy scavenging (35) may lead to devices surpassing even those proposed 
in science fiction.  
Materials and Methods 
Robot Design 
The structural components of the robot are fabricated from stiff waterproof polymers (Fig. 1D). 
TKHVHFRQVLVWRIWKHUDFNPDFKLQHGGHOULQUHLQIRUFHGZLWKD´GLDPHWHUVWDLQOHVVVWHHOURG
and two end caps molded from urethane resin (Smooth-Cast ONYX Slow, Reynolds Advanced 
0DWHULDOV7KUHHDGGLWLRQDOVWDLQOHVVVWHHOURGV´GLDPHWHUDWWDFKHGWRWKHWZRFDSVDFWDVDQ
endoskeleton to stiffen the frame and also to prevent surrounding tissue from herniating into the 
mechanism.  
The robotic mechanism is comprised of a machined aluminium carriage that slides along the rack 
under the control of a motor-driven (298:1 gear box, 40 oz-in torque, Pololu Corp.) worm gear 
(A1C55-N24, SDP/SI). The worm gear is nonbackdriveable, meaning that when the motor is 
turned off, the position of the carriage does not change. A potentiometer (652-3266W-1-103LF, 
Bourns Inc.) rotating with the worm gear, measures displacement of the carriage along the rack, 
and is fixed to a steel frame (polished gray steel, Shapeways) that attaches to the carriage. The 
lower ring is attached to the carriage by a hinge joint that transmits the tensile force applied by the 
tissue on the ring to a force sensor (FSS Low Profile Force Sensors, FSS1500NST, Honeywell 
Inc.) mounted on the carriage.  
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The tubular organ is attached to the implant by two rings (Fig. 1C-F). Six sutures spaced equally 
about the circumference are used to attach each ring to the esophagus. The design is intended to 
provide uniform distribution of traction forces around WKHRUJDQ¶Vcircumference to support tubular 
growth and to minimize the chance of the sutures tearing out of the tissue. The rings are fabricated 
frRPZHOGHG´GLDPHWHUVWDLQOHVVVWHHOURGVWRFN7KHRSHQULQJGHVLJQHQDEOHVDWWDFKPHQWWR
connected organs and adjustment of ring diameter (Fig. 1E). Grooves on the outer surface of the 
ring prevent suture from sliding along or off the ring. To enable the rings to be first sutured to the 
organ and then attached to the implant, each ring includes a U-shaped connector. This connector 
slides onto a mating T-VKDSHG VWDLQOHVV VWHHO FRQQHFWRU ORFDWHG RQ WKH RXWVLGH RI LPSODQW¶V
encapsulation (Fig. 1E,F). 
Robot Encapsulation 
The robot mechanism and electronics are completely sealed inside a biocompatible medical-grade 
encapsulation that permits sterilization using ethylene oxide. The main encapsulation component 
LVD´WKLFNF\OLQGULFDOVLODVWLFVNLQ352034-007R, Bentec Medical) that is reinforced with 
an embedded polyester mesh. Rather than being stretched taut between the end caps, excess 
material is used to create folds on each side of the moving attachment ring (Fig.1C). This allows 
the ring to translate along the implant body without stretching the silastic skin ± which would 
interfere with ring force measurement and also increase required motor torque. Molded silastic 
caps (MDX4-4210, Dow Corning Corp.) seal each end of the cylindrical skin. Electrical 
conductors are encased in a 20Fr silastic tube (GS75160-20, Bentec Medical) integrated with the 
bottom cap and attached to Ethernet connectors. The I-shaped connectors for the tissue attachment 
rings are clamped to the underlying mechanism by screws that pass through the encapsulation. 
These attachments as well as all joints of the encapsulation were sealed using a medical-grade 
silicone adhesive (Type A, Dow Corning Corp.). The weight of the encapsulated implant is 99.4g 
and the rings weigh 3.5g. 
Control and Communication 
The implant is connected by cable to a wearable control unit located outside the body that 
integrates all circuitry related to control, sensing and communication with a battery power supply 
(Figs. 2A,4D). The main electronic components are a microcontroller (Baby Orangutan B-328, 
Pololu Corp.), a differential amplifier (MCP6001, Microchip Technology, Inc) for the force sensor, 
a voltage regulator, and a Bluetooth transmitter module (Blue Smirf Silver, Sparkfun Electronics). 
The power supply consisted of four 9V batteries connected in parallel. A low-level controller, 
programmed in C++, uses Proportional Integral Derivative (PID) control to position the moving 
attachment ring to achieve control commands consisting of either a desired ring-to-ring spacing or 
desired ring force. Control commands are received via Bluetooth from a laptop computer. These 
commands can be entered individually or can be preprogrammed to produce a desired waveform, 
e.g., adjustment once per day or every few minutes. Sensor data is streamed to the laptop by 
Bluetooth at a sampling frequency of 6.6Hz. A graphical user interface on the laptop allows real 
time data plotting, control command entry, controller gain adjustment and emergency stopping of 
the motor.  
Animal Groups 
Two animal groups were used in these experiments. Both groups were comprised of young 
Yorkshire female pigs of approximately the same weight (43.5 +/- 3.7 kg, mean mass ± one 
standard deviation) and age (14.4 +/- 1.0 weeks). The surgical group (n=5) underwent esophageal 
lengthening as described below. Within this group, 3 animals underwent 9 days of lengthening and 
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2 animals underwent 8 days of lengthening. The difference in duration was due solely to procedure 
scheduling constraints. The naïve control group (n=3) underwent no surgical procedure. For both 
groups, tissue samples were collected immediately following animal sacrifice.  
Surgical Procedure and Animal Care 
The surgical procedure is inspired by the Foker technique for the clinical treatment of long-gap 
esophageal atresia (Fig. 1G) (21). In this technique, suture loops are attached to the ends of the 
esophagus and passed through intercostal spaces to be tied off against force-distributing buttons 
positioned on the EDE\¶VEDFN6XWXUH IRUFH LVPDQXDOO\ LQFUHDVHG HDFKGD\ E\ LQVHUWLQJ VKRUW
lengths of millimeter-diameter tubing between the suture loops and buttons. During the 1-4 weeks 
of traction, patients are maintained in a state of sedation and paralysis in the Intensive Care Unit 
(ICU) so that the sutures do not tear out of the esophagus due to musculoskeletal motion.   
Animal care followed procedures prescribed by the Institutional Animal Care and Use Committee. 
After induction of anesthesia, the animal was intubated and placed on ventilation. A right 
thoracotomy was performed at the 7th intercostal space and the esophagus was dissected from the 
surrounding adventitia. A tunnel was created at the 9th intercostal space and the implant cable was 
passed through it and connected to the control box. Keeping the implant body within the sterile 
field, but outside the surgical cavity, the two attachment rings were sutured to the esophagus at a 
nominal separation distance of 20mm (Fig. 4A). Additionally, two pairs of titanium clips 
(LIGACLIP® Extra Ligating Clips, LT300, Ethicon LLC.) were placed 20mm proximal and distal 
to the rings. The clips in each pair were placed 20mm apart to provide the means to track 
lengthening of the esophagus outside the traction region. These segments are referred to as the 
proximal control segment and the distal control segment.  
Subsequently, the robot was placed in the right thorax and attached to the rings (Fig. 4A). To 
prevent adhesions of the esophagus to surrounding tissue as well as to protect the lungs, a silastic 
sheet (PR72034-007R, Bentec Medical) was wrapped around the dissected esophagus and implant 
(Fig. 4B). The sheet was sutured to itself forming a cylinder and also sutured to the esophagus to 
prevent it from sliding along the organ (Fig. 4C). The right thorax was closed in three layers. Two 
chest tubes were used to remove air from the pleural cavity.  
Patency of the esophagus and operability of the implant were assessed immediately after surgery 
using X-ray or fluoroscopy. The pig was then dressed in a vest (SAI Infusion Technologies) 
containing a zippered pocket on its back into which the control unit and batteries were placed. The 
animal was then weaned from anesthesia. During the subsequent days of the experiment, the 
animals were fed three times per day with a slurry diet consisting of milled grains, water and juices. 
They also received Omeprazole (to limit stomach acid), Cephalexin (antibiotic) and Fentanyl (pain 
reliever). The batteries were changed once per day. The animals gained 2.2 +/- 1.3 kg in weight 
between surgery and sacrifice. In addition to immediately after surgery, imaging was also 
performed on day 4 and on the final day (10 or 11). 
Daily Implant Adjustment 
After allowing the animals to recover for one full day, traction was initiated on the morning of Day 
2. During this first traction adjustment, the rings were advanced sufficiently to apply a force of 
~2N to the segment between the rings. This corresponded to an average displacement of 7.2 ± 
2.4mm. Subsequent adjustments were performed each morning at approximately the same time 
(9:00 am) with the distance between the rings increased by an average of 2.5mm per day (Figs. 
2B,2D).  
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Segment Length Measurement 
The implant provided continuous length measurement of the segment undergoing traction. X-ray 
and fluoroscopic images taken on Days 0, 4 and the final day (Day 10 or11) were used to measure 
the length of the proximal and distal control segments. Prior to sacrifice, the implant was adjusted 
in an iterative fashion to remove the traction force from the lengthened segment. This was 
performed over a 10-15 minute period to allow for tissue relaxation. The ring distance 
corresponding to zero force was taken as the final segment length. These measurements were in 
good agreement with manual measurements of the excised tissue. The lengths of the control 
segments and stretched segment are plotted in Fig. 2D. The data for the proximal control segment 
in one animal was discarded since the measurement indicated that at least one of the clips had 
become detached from the esophagus.  
Physical Measurement of Lumen Diameter 
To measure the lumen diameter, the wall of the excised esophagus was cut longitudinally and 
unrolled to a rectangular shape (Fig. 2E). Width measurements of the esophagus in this 
configuration represent the circumference of the lumen. 
An image was taken of each esophagus with a ruler next to it. Using ImageJ (National Institutes 
of Health), 20 width measurements were made for each of the three segments of interest (proximal 
control, lengthened and distal control) in the surgical group. Sixty measurements of width were 
taken for each esophagus in the naïve group. Average lumen circumferences were computed from 
these data sets.  
Histology 
Esophageal tissue samples were collected from each animal in the surgical and naïve groups. Both 
longitudinal and transverse samples were prepared by fixing in 10% neutral-buffered formalin and 
then embedded in paraffin. SectioQVZHUHFXWDQGVWDLQHGZLWK0DVVRQ¶VWULFKURPHXVLQJURXWLQH
histological protocols. DAPI fluorescent staining was used for characterizing nuclear density. To 
quantify muscle cell proliferation, a double stain protocol was developed for porcine esophagus 
using anti-desmin protein antibody (D8281, Sigma-Aldrich; 1:4000 dilution) and the Ki-67 
antibody (VP-RM04, Vector Labs; 1:250 dilution). Sequential double staining was performed on 
the Leica Bond III staining platform. Antigen retrieval was performed using Bond Epitope 
Retrieval 1 for 30 minutes. Ki-67 was detected and developed using Bond Polymer Refine 
Detection Kit, and Desmin was detected and developed using Bond Polymer Refine Red Detection 
Kit.  
Specimens were visualized using a microscope (BX53, Olympus America Inc.) and image 
acquisition was carried out using AxioVision Microscopy Software (v. 4.8.2, Carl Zeiss 
Microscopy) and ImageScope (v. 12.3.0.5056, Leica Biosystems GmbH).  
Thickness of the Muscularis Externa 
To measure layer thickness, longitudinally-FXW0DVVRQ¶V WULFKURPHVWDLQHGVDPSOHVZHUHXVHG
Three images at 5X magnification, evenly spaced along the length of the tissue, were taken. The 
filenames were blinded using an MD5 hash before being measured. Twenty evenly spaced 
measurements were taken using ImageJ in each of the 3 images resulting in 60 measurements per 
slide for each layer. These measurements were then averaged. A t-test was used to compare 
surgical and naïve control groups. The results are presented in Fig. 5A.  
Muscle Fiber Diameter 
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To investigate cell hypertrophy, a study of skeletal muscle fiber cross sectional diameter was 
performed. Skeletal muscle fibers are clearly visible on Desmin stained slides and are arranged in 
both longitudinal and circular layers in the muscularis externa. Fiber diameters were compared 
since they are less sensitive to sample cutting angle than fiber length. Four longitudinally cut tissue 
samples were used for the circular muscle layer and 4 circumferentially-cut tissue samples were 
used to measure the longitudinal muscle layer. Using ImageJ, the two maximally distant points of 
each fiber cross section were selected manually and the software computed the distance between 
them (Fig. 3B). An average of 120 muscle cell diameters were counted per pig (min 75, max 175). 
The averages are shown in Fig. 5B. A t-test was used to compare surgical and naïve control groups. 
There was no significant difference in skeletal fiber diameter for either the circular muscle layer 
or the longitudinal muscle layer. 
Nuclear Density 
Longitudinally-cut tissue samples stained with DAPI immunofluorescent stain were used to 
quantify nuclear density. Up to twelve 10X magnification images were used when possible 
depending on the amount of available tissue. If the full area of the layer was covered in less than 
twelve fields of view, then only as many images were required to cover the entire area of the layer 
were used. The minimum number of fields used in any one animal was six, and the minimum 
number of nuclei counted was 1484. 
A morphological algorithm was written in Python and openCV to count the number of nuclei in 
each image. Nuclei had a variety of shapes and sizes, and some nuclei appeared in clusters of 20 
or more. The algorithm was designed to compensate for these challenges. First, all DAPI positive 
contours in the image were identified. Contours were then sorted to eliminate those falling outside 
minimum and maximum size constraints (based on manual identification of the largest and 
smallest nuclei in the full data set). The mean nucleus size and standard deviation were then 
computed from the reduced contour list. All contours were then divided into one of two categories: 
(1) Single nucleus if the area of the contour is less than the median or larger than the median but 
higher than 84% circularity, (2) Multi-nucleus cluster if area is larger than median area, smaller 
than median area plus 2 standard deviations and low circularity, or if area is larger than median 
area plus 2 standard deviations. The number of nuclei in a multi-nucleus cluster was estimated 
according to the following equation:  ?݊ݑ݈ܿ݁݅ ൌ ݎ݋ݑ݊݀ሺ ஼௟௨௦௧௘௥஺௥௘௔ெ௘௔௡ே௨௖௟௘௨௦஺௥௘௔ሻ. This algorithm gave 
good agreement with manual counting on sample images.  
The nuclear density of both the lengthened and naïve samples was observed to increase along the 
length of the esophagus. This corresponds to the increasing ratio of smooth to skeletal muscle cells 
along the length of the esophagus. Smooth muscle cell clusters have a much higher nuclear density 
than skeletal muscle cells leading to higher densities at distal locations. Based on a t-test, 
comparisons of the densities of the lengthened and naïve tissue segments in each of the three 
sections show that they are not statistically different.  
Nuclear Proliferation at Time of Sacrifice 
To provide a direct measurement of cell proliferation at the time of sacrifice, we used a dual Ki67 
and Desmin staining protocol to both detect proliferating nuclei and to be able to associate nuclei 
with muscle cells. We computed the percentage of Ki67-marked muscle-cell nuclei in the 
muscularis externa in the surgical and naïve groups.  
Longitudinal tissue samples were used to quantify nuclear proliferation. Eight images at 32X 
magnification were used. Total nuclei were counted from the digital photographs of these fields. 
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The names of the files were blinded before counting. Ki67-marked nuclei were counted blind 
through the eyepiece of the microscope, as a high fidelity of color was required to distinguish 
proliferating cells from nonproliferating cells. The percentage of proliferating muscle nuclei was 
shown to be larger in the surgical group compared to the naïve group (Fig. 5E) as computed with 
the Mann-Whitney U-test.  
Percentage of Lengthening Due to Muscle versus Collagen (Fibrosis) 
The muscularis externa is composed of groups of smooth and skeletal muscle cells interconnected 
by collagen, as seen in Fig. 3D. Given this structure, tissue along the direction of lengthening is 
comprised partially of muscle and partly of collagen. To compute how much of the lengthening 
was due to muscle cell proliferation and how much was due to collagen proliferation, we 
considered lines parallel to the direction of elongation and measured the ratio of the lengths of the 
cell types intersecting these lines. Computing the average ratio over all possible lines in a tissue 
region is equivalent to computing the ratio of cell-type areas in that region.  
:HXVHGORQJLWXGLQDO0DVVRQ¶V7ULFKURPH-stained tissue samples from the lengthened segments 
in the surgical group and from the naïve group. Eight, 10X magnification images of the muscularis 
externa were obtained if sufficient tissue was available on a slide. If the full area of the layer was 
covered in less than eight fields of view, then only as many images as were required to cover the 
entire area of the layer were used (minimum fields used was 3). 
For each animal, a set of three color thresholds in the HSV color space were chosen. Red 
represented muscle, blue represented collagen and white represented a void of tissue in the image. 
Once the thresholds were set, an algorithm written in Python and OpenCV was used to threshold 
each image into three parts, removed the tissue voids, and tallied the area of each tissue type.  
Using this method, the muscle / collagen ratio of naïve tissue was found to be 93% / 7%. In 
lengthened tissue, the muscle / collagen ratio was 80% / 20% (Fig. 5F).  Since the ratio changed, 
we need to solve a set of linear equations to determine the fraction of lengthening due to muscle 
cell proliferation versus the fraction due to collagen proliferation. Defining the following variables,  ܮ௜ ൌ total initial tissue segment length  ߜ ൌ increase in tissue segment length ݈௠௜ ൌ  ?Ǥ ? ?ܮ௜ ൌinitial length comprised of muscle cells (measured in naïve tissue) ݈௖௜ ൌ  ?Ǥ ? ?ܮ௜ ൌinitial length comprised of collagen (measured in naïve tissue) ݈௠௙ ൌ  ?Ǥ ?൫ܮ௜ ൅ ߜ൯ ൌfinal length comprised of muscle cells ݈௖௙ ൌ  ?Ǥ ?൫ܮ௜ ൅ ߜ൯ ൌfinal length comprised of collagen 
we can solve for the lengthening due to muscle and collagen proliferation using the following 
equations: ൫݈௠௙ െ ݈௠௜ ൯ܮ௜ ൌ ൫ ?Ǥ ?൫ܮ௜ ൅ ߜ൯ െ  ?Ǥ ? ?ܮ௜൯ܮ௜ ൌ  ?Ǥ ?ሺ ?Ǥ ? ?ሻ െ  ?Ǥ ? ?ൌ  ?Ǥ ? ? ൫݈௖௙ െ ݈௖௜ ൯ܮ௜ ൌ ൫ ?Ǥ ?൫ܮ௜ ൅ ߜ൯ െ  ?Ǥ ? ?ܮ௜൯ܮ௜ ൌ  ?Ǥ ?ሺ ?Ǥ ? ?ሻ ൅  ?Ǥ ? ?ൌ  ?Ǥ ? ? 
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These numbers indicate the segment lengthening due to muscle proliferation alone (49%) and 
collagen proliferation alone (28%) with their sum yielding the total observed lengthening of 77%. 
We can also express these numbers as fractions of the total 77% lengthening, ቆ൫݈௠௙ െ ݈௠௜ ൯ܮ௜ ቇቀߜܮ௜ቁ ൌ  ?Ǥ ? ? ?Ǥ ? ?ൌ  ?Ǥ ? ? ቆ൫݈௖௙ െ ݈௖௜ ൯ܮ௜ ቇቀߜܮ௜ቁ ൌ  ?Ǥ ? ? ?Ǥ ? ?ൌ  ?Ǥ ? ? 
These numbers indicate that 63% of lengthening was due to muscle cell proliferation and 37% was 
due to collagen proliferation.  
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Fig1. Robotic implant for tubular tissue growth. (A) Long-gap esophageal atresia ± Implant applies 
forces, F, to disconnected esophageal segments. After inducing sufficient growth, the segments are 
surgically connected to form a complete esophagus. (B) Short bowel syndrome ± Implant applies forces, F, 
to connected segment of bowel. By inducing sufficient lengthening to support the absorption of necessary 
calories and fluids, a dependence on intravenous feeding can be eliminated. (C) Robot is covered by 
biocompatible waterproof skin and is attached to tubular organ by two rings (esophageal segment shown). 
Upper ring is fixed to robot body while lower ring translates along body. (D) Robot with skin removed to 
show motor drive system and sensors. Rotation of worm gear causes lower ring to translate along body.  
 (E) Rings detach from robot body to facilitate attachment to tubular organ. (F) Tissue is attached to the 
ring using sutures. (G) Foker technique for treating long-gap esophageal atresia (21) ± Sutures externalized 
RQWKHSDWLHQW¶VEDFNDUHXVHGWRDSSO\IRUFHV, F, to esophageal segments.  
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Fig 2. Esophageal lengthening experiments. (A) Implant controller located in vest pocket communicates 
wirelessly with laptop computer. (B) Force and position data recorded over a 24-hour period. (C) 
Fluoroscopic image showing flow of contrast agent through esophagus during traction. (D) Esophageal 
segment length versus time. Surgery occurs on Day 0. Segment length corresponds to distance between 
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implant attachment rings for lengthened segment (blue) and distance between clips for control segments 
(green). Average values at midpoint fluoroscopy and sacrifice are given (in red and purple, respectively). 
Two animals were survived to Day 10 and three were survived to Day 11. *** p<0.0001. (E) Resected 
esophagus cut along its length and unrolled along its circumference to show epithelium. Rings are placed 
adjacent to attachment locations for reference. Note normal appearance of tissue and uniform diameter of 
lengthened section.  
 
                   Naïve Group                Surgical Group 
 
 
 
A 
 
 
 
 
 
 
 
B 
 
 
  
 
 
 
C 
 
  
 
 
D 
 
 
 
 
 
Fig 3. Esophageal tissue histology. (A) Longitudinal sections of Desmin stained tissue (1X 
magnification) showing tissue layers: Muscularis Externa (ME), comprised of Longitudinal Muscle (LM) 
and Circular Muscle (CM); Submucosa (SM); Muscularis Mucosa (MM); Lamina Propria (LP); and 
EP 
CM 
LM 
ME 
CM 
LM 
ME 
EP 
MM 
MM 
SM 
LP 
LP 
SM 
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Epithelium (EP). (B) Longitudinal sections of Desmin stained tissue (20X magnification) illustrating 
diameter measurement of skeletal muscle fiber cross sections. (C) Longitudinal sections of DAPI stained 
tissue (10X magnification) used to assess nuclear density. (D) Longitudinal sections of 0DVVRQ¶V
trichrome stained tissue (20X magnification) for measuring relative fractions of muscle (pink) and 
collagen (blue).  
 
 
 
Fig. 4. Implant surgery. (A) Suturing of rings to esophagus. (B) Silicone sheet is inserted behind 
esophagus and implant is connected to attachment rings. (C) Implant and esophagus, wrapped in silicone 
sheet, positioned between the rib cage and right lung prior to surgical closure.  (D) Control electronics are 
housed in a vest pocket. (E) Necropsy view of fibrotic capsule surrounding implant. Bulges due to 
proximal ring and distal end cap can be seen in capsule.  
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Fig. 5. Histology results comparing surgical and naïve groups. Asterisks indicate p-values less than 
0.05 with specific values given in subcaptions. Error bars indicate one standard deviation unless otherwise 
noted. (A) Thickness of muscularis externa. (B) Skeletal muscle fiber diameter in longitudinal and 
circular layers of muscularis externa comparing lengthened surgical and naïve segments. (C) Nuclear 
density of muscularis externa. (D) Nuclear density in epithelium. (E) Median percentage proliferating 
muscle cells in muscularis externa of lengthened surgical segment versus naïve tissue. Error bars 
represent first and third quartiles (p=0.025). (F) Percentage of collagen in lengthened surgical segment 
versus naïve tissue. (p=0.002)  
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Movie 1 
Fluoroscopic video shows in vivo adjustment of implant consisting of increase in segment length of 2mm. 
Barium is administered before and after adjustment to assess patency of the esophagus.  
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